Abstract:Objective: To present recent concepts on the molecular pathogenesis of tumors of soft tissue and bone, and on the use of molecular genetic methods, including their significance as diagnostic markers and prognostic indicators. Data sources and study selection: Reports on tumors of bone and/or soft tissue published in the English language literature and observations made using specimens available at the Departments of Pathology at Albany Medical College and Loyola University Medical Center. Data extraction and synthesis: Studies on bone and soft tissue tumors containing chromosomal or genetic evaluation were selected for further analysis. Specific chromosomal abnormalities, such as numerical aberrations or translocations with production of fusion genes, were classified according to the tumor of origin. Data were also collected on mutations in tumor suppressor genes, genes coding for growth factors or their receptors, and genes coding for tyrosine kinases. Also noted were mutations of uncertain significance, for which the pathogenic connection between tumor production and mutated gene function is still unclear. Conclusions: In general, the mutations reported interfere with the action of peptide growth factors coordinating mesenchyme proliferation and differentiation, although membrane-bound receptors expressing the intracellular signaling modifier, tyrosine kinase activity, have also been involved. Functional types of genes most commonly affected include tumor suppressors, oncogenes, and nuclear transcription factors. Thus, the mutations involved in the pathogenesis of soft tissue and bone tumors have affected multiple genes. Moreover, aberrant fusion gene products may be formed in tumoral tissue and may then act as transcription regulators stimulating cellular proliferation. Cytogenetic studies help at the clinical level by demonstrating aneuploidy and increased ploidy, which may correlate with malignant behavior. Diagnostic tumor-specific chromosomal translocations may be detected with Southern hybridization analysis, polymerase chain reaction, reverse-transcription polymerase chain reaction, or with the fluorescence in situ hybridization technique. Notably, early metastatic disease may be detectable in blood specimens using polymerase chain reaction or reverse-transcription polymerase chain reaction techniques.

Can DNA Methylation Profiling Classify Histologic Subtypes and Grades in Soft Tissue Sarcoma?

A 3-DNA Methylation Signature As a Novel Prognostic Biomarker in Patients with Sarcoma by Bioinformatics Analysis

Integrative DNA methylation and gene expression analysis in high-grade soft tissue sarcomas

Sarcoma classification by DNA methylation profiling

Sarcoma diagnosis by DNA methylation classifier: A systematic review, current status and future prospects

Identification of Methylation Signatures and Rules for Sarcoma Subtypes by Machine Learning Methods.

Over-methylation of Histone H3 Lysines Is a Common Molecular Change Among the Three Major Types of Soft-tissue Sarcoma in Patient-derived Xenograft (PDX) Mouse Models

DNA Methylation Based Molecular Subtypes Predict Prognosis in Breast Cancer Patients

Proteomic characterization identifies clinically relevant subgroups of soft tissue sarcoma

Potential Application of Genomic Profiling for the Diagnosis and Treatment of Patients with Sarcoma.

Soft tissue sarcomas: From a morphological to a molecular biological approach

Molecular Profiling Defines Three Subtypes of Synovial Sarcoma

DNA methylation-based epigenetic signatures predict somatic genomic alterations in gliomas

DNA methylation signatures for breast cancer classification and prognosis

Abstract 7564: DNA methylation profiling identifies two distinct groups of oligosarcoma, IDH-mutant with distinct genetic alterations and clinical outcomes

Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma

Molecular subtypes based on DNA methylation predict prognosis in colon adenocarcinoma patients

DNA methylation-based classification and identification of renal cell carcinoma prognosis-subgroups

Molecular pathology of soft tissue and bone tumors. A review

DNA Methylation Profiling of Salivary Gland Tumors Supports and Expands Conventional Classification

DNA methylation data–based molecular subtype classification related to the prognosis of patients with cervical cancer